<DOC>
	<DOCNO>NCT01121029</DOCNO>
	<brief_summary>The purpose study determine autologous nonmyeloablative hematopoietic stem cell transplantation able induce prolong significant increase C-peptide level associate absence reduction daily insulin .</brief_summary>
	<brief_title>Hematopoietic Stem Cell Transplantation Type 1 Diabetes Mellitus</brief_title>
	<detailed_description>Patients type 1 DM depend exogenous insulin administration survival control long-term complication . The best-established treatment tight control blood glucose achieve frequent daily injection continuous subcutaneous infusion insulin , ie , intensive insulin therapy . Although insulin therapy develop enormously , even modern technology allow maintenance normoglycemia . Since establishment autoimmune etiology type 1 DM late 1970s , many clinical trial analyze effect different type immune intervention demonstrate beta-cell preservation achievable target different degree . Controlled trial biological study necessary confirm role treatment change natural history type 1 DM . This prospective pilot study enroll patient type 1 diabetes mellitus within first month diagnosis , clinical laboratory finding . The donor stimulation cyclophosphamide , filgrastim , mesna . The cell recollect peripheral blood apheresis refrigerate . The patient receive nonmyeloablative conditioning regimen cyclophosphamide fludarabine , , cell inject intravenously . They receive standard regimen post-transplant prophylaxis . The duration use prophylactic drug scheme depend patient 's recovery time . The reinfusion stem cell complete last dose cyclophosphamide , peripheral vein . Lately , every three month , C-Peptide level , glucose insulin serum level measure .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Patients newly diagnose type 1 diabetes mellitus Patients HIV Patients Hepatitis Patients hematologic disease Patients hearth failure Renal , Hepatic psychiatric disease Pregnant patient</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>